Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ERIS LIFESCIENCES vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ERIS LIFESCIENCES ZYDUS LIFESCIENCES ERIS LIFESCIENCES/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 50.6 22.2 228.4% View Chart
P/BV x 7.2 4.8 149.7% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 ERIS LIFESCIENCES   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ERIS LIFESCIENCES
Mar-24
ZYDUS LIFESCIENCES
Mar-24
ERIS LIFESCIENCES/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs9711,030 94.3%   
Low Rs565483 117.1%   
Sales per share (Unadj.) Rs147.7194.3 76.0%  
Earnings per share (Unadj.) Rs29.238.1 76.7%  
Cash flow per share (Unadj.) Rs42.645.7 93.3%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Avg Dividend yield %00.4 0.0%  
Book value per share (Unadj.) Rs189.7197.1 96.3%  
Shares outstanding (eoy) m136.031,006.23 13.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.23.9 133.6%   
Avg P/E ratio x26.319.9 132.5%  
P/CF ratio (eoy) x18.016.6 108.8%  
Price / Book Value ratio x4.03.8 105.5%  
Dividend payout %07.9 0.0%   
Avg Mkt Cap Rs m104,470761,065 13.7%   
No. of employees `000NANA-   
Total wages/salary Rs m4,03827,890 14.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m20,091195,474 10.3%  
Other income Rs m2383,694 6.4%   
Total revenues Rs m20,330199,168 10.2%   
Gross profit Rs m6,74852,848 12.8%  
Depreciation Rs m1,8267,641 23.9%   
Interest Rs m848812 104.4%   
Profit before tax Rs m4,31248,089 9.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3429,775 3.5%   
Profit after tax Rs m3,97138,314 10.4%  
Gross profit margin %33.627.0 124.2%  
Effective tax rate %7.920.3 39.0%   
Net profit margin %19.819.6 100.8%  
BALANCE SHEET DATA
Current assets Rs m23,790114,198 20.8%   
Current liabilities Rs m26,09053,397 48.9%   
Net working cap to sales %-11.431.1 -36.8%  
Current ratio x0.92.1 42.6%  
Inventory Days Days1730 56.5%  
Debtors Days Days7797 78.7%  
Net fixed assets Rs m44,398161,352 27.5%   
Share capital Rs m1361,006 13.5%   
"Free" reserves Rs m25,675197,289 13.0%   
Net worth Rs m25,811198,295 13.0%   
Long term debt Rs m6,5450-   
Total assets Rs m68,188276,366 24.7%  
Interest coverage x6.160.2 10.1%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.30.7 41.7%   
Return on assets %7.114.2 49.9%  
Return on equity %15.419.3 79.6%  
Return on capital %15.924.7 64.7%  
Exports to sales %043.0 0.0%   
Imports to sales %0.19.9 1.2%   
Exports (fob) Rs mNA84,117 0.0%   
Imports (cif) Rs m2319,274 0.1%   
Fx inflow Rs m084,117 0.0%   
Fx outflow Rs m2319,274 0.1%   
Net fx Rs m-2364,843 -0.0%   
CASH FLOW
From Operations Rs m4,86032,279 15.1%  
From Investments Rs m-18,545-14,752 125.7%  
From Financial Activity Rs m13,798-18,104 -76.2%  
Net Cashflow Rs m382-748 -51.1%  

Share Holding

Indian Promoters % 54.9 75.0 73.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 26.6 18.2 146.6%  
FIIs % 8.0 7.5 106.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.1 25.0 180.4%  
Shareholders   46,346 370,863 12.5%  
Pledged promoter(s) holding % 18.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ERIS LIFESCIENCES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on ERIS LIFESCIENCES vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ERIS LIFESCIENCES vs Cadila Healthcare Share Price Performance

Period ERIS LIFESCIENCES Cadila Healthcare S&P BSE HEALTHCARE
1-Day 0.60% 0.21% 0.67%
1-Month 2.65% -5.80% -3.33%
1-Year 48.74% 48.91% 43.33%
3-Year CAGR 22.40% 27.56% 19.82%
5-Year CAGR 26.46% 31.19% 26.27%

* Compound Annual Growth Rate

Here are more details on the ERIS LIFESCIENCES share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of ERIS LIFESCIENCES hold a 54.9% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ERIS LIFESCIENCES and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, ERIS LIFESCIENCES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Cadila Healthcare paid Rs 3.0, and its dividend payout ratio stood at 7.9%.

You may visit here to review the dividend history of ERIS LIFESCIENCES, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 239 Points Higher | Nifty Above 23,500 | HDFC Bank & Tech Mahindra Top Gainers Sensex Today Ends 239 Points Higher | Nifty Above 23,500 | HDFC Bank & Tech Mahindra Top Gainers(Closing)

On Tuesday, Indian share markets traded on a positive note throughout the session and ended marginally higher.